AC Immune (ACIU) EBIT Margin (2015 - 2026)
AC Immune (ACIU) posted quarterly EBIT Margin of 1321.54% for Q1 2026, up 63503.0% year-over-year from N/an in Q1 2025, and up 68.97% quarter-over-quarter from 4258.58% in Q4 2025.
Powered by 
Analysis
AC Immune (ACIU) EBIT Margin (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported EBIT Margin for 10 consecutive years, with 1321.54% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT Margin rose 63503.0% year-over-year to 1321.54%; the TTM figure through Mar 2026 stood at 1749.24% (down 157246.0% YoY), while the FY2025 annual figure was 1940.05%, down 174825.0% from the prior year.
- EBIT Margin grew to 1321.54% in Q1 2026 per ACIU's latest filing, from 4258.58% in the prior quarter.
- Across five years, EBIT Margin topped out at 28.52% in Q3 2024 and bottomed at 53420.0% in Q4 2022.
- Historically, EBIT Margin has averaged 6916.81% across 4 years, with a median of 1679.54% in 2024.
- On a YoY basis, EBIT Margin climbed as much as 156656 bps in 2025 and fell as far as 262111 bps in 2025.
- AC Immune's EBIT Margin stood at 53420.0% in 2022, then jumped by 97 bps to 1637.47% in 2024, then slumped by 160 bps to 4258.58% in 2025, then soared by 69 bps to 1321.54% in 2026.
- Business Quant data shows ACIU's EBIT Margin at 1321.54% in Q1 2026, 4258.58% in Q4 2025, and 1721.62% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | 7.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.89% |
| Mar 31, 2026 | -1,321.54% |
| Dec 31, 2025 | -4,258.58% |
| Sep 30, 2025 | -1,721.62% |
| Jun 30, 2025 | -1,484.53% |
| Mar 31, 2025 | -1,956.57% |
| Dec 31, 2024 | -1,637.47% |
| Sep 30, 2024 | 28.52% |
| Jun 30, 2024 | -3,051.09% |
| Dec 31, 2022 | -1,869,700.00% |
| Sep 30, 2022 | -342.22% |
| Dec 31, 2020 | -2,061.97% |
| Sep 30, 2020 | -1,674.53% |
| Jun 30, 2020 | -1,448.48% |
| Mar 31, 2020 | -59.46% |
| Dec 31, 2019 | -2,188.72% |
| Sep 30, 2019 | 53.81% |
| Jun 30, 2019 | -977.76% |
| Mar 31, 2019 | 80.16% |
| Dec 31, 2018 | -88.22% |